• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酸敏感可脱落聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒增加慢性炎症部位肿瘤坏死因子-α小干扰RNA的递送

Acid-Sensitive Sheddable PEGylated PLGA Nanoparticles Increase the Delivery of TNF-α siRNA in Chronic Inflammation Sites.

作者信息

Aldayel Abdulaziz M, Naguib Youssef W, O'Mary Hannah L, Li Xu, Niu Mengmeng, Ruwona Tinashe B, Cui Zhengrong

机构信息

Pharmaceutics Division, College of Pharmacy, The University of Texas at Austin, Austin, Texas, USA.

出版信息

Mol Ther Nucleic Acids. 2016 Jul 19;5(7):e340. doi: 10.1038/mtna.2016.39.

DOI:10.1038/mtna.2016.39
PMID:27434685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5330937/
Abstract

There has been growing interest in utilizing small interfering RNA (siRNA) specific to pro-inflammatory cytokines, such as tumor necrosis factor-α ( TNF-α), in chronic inflammation therapy. However, delivery systems that can increase the distribution of the siRNA in chronic inflammation sites after intravenous administration are needed. Herein we report that innovative functionalization of the surface of siRNA-incorporated poly (lactic-co-glycolic) acid (PLGA) nanoparticles significantly increases the delivery of the siRNA in the chronic inflammation sites in a mouse model. The TNF-α siRNA incorporated PLGA nanoparticles were prepared by the standard double emulsion method, but using stearoyl-hydrazone-polyethylene glycol 2000, a unique acid-sensitive surface active agent, as the emulsifying agent, which renders (i) the nanoparticles PEGylated and (ii) the PEGylation sheddable in low pH environment such as that in chronic inflammation sites. In a mouse model of lipopolysaccharide-induced chronic inflammation, the acid-sensitive sheddable PEGylated PLGA nanoparticles showed significantly higher accumulation or distribution in chronic inflammation sites than PLGA nanoparticles prepared with an acid-insensitive emulsifying agent (i.e., stearoyl-amide-polyethylene glycol 2000) and significantly increased the distribution of the TNF-α siRNA incorporated into the nanoparticles in inflamed mouse foot.

摘要

在慢性炎症治疗中,利用针对促炎细胞因子(如肿瘤坏死因子-α,TNF-α)的小干扰RNA(siRNA)的兴趣日益浓厚。然而,需要一种能够在静脉给药后增加siRNA在慢性炎症部位分布的递送系统。在此,我们报告,掺入siRNA的聚(乳酸-共-乙醇酸)(PLGA)纳米颗粒表面的创新功能化显著增加了siRNA在小鼠模型慢性炎症部位的递送。掺入TNF-α siRNA的PLGA纳米颗粒通过标准双乳液法制备,但使用硬脂酰腙-聚乙二醇2000(一种独特的酸敏感表面活性剂)作为乳化剂,这使得(i)纳米颗粒聚乙二醇化,以及(ii)聚乙二醇化在低pH环境(如慢性炎症部位的环境)中可脱落。在脂多糖诱导的慢性炎症小鼠模型中,酸敏感可脱落聚乙二醇化PLGA纳米颗粒在慢性炎症部位的积累或分布显著高于用酸不敏感乳化剂(即硬脂酰酰胺-聚乙二醇2000)制备的PLGA纳米颗粒,并显著增加了掺入纳米颗粒的TNF-α siRNA在发炎小鼠足部的分布。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/8c18264bac35/mtna201639f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/6f1dc5555d13/mtna201639f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/05286e6c2247/mtna201639f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/2a31a08c147a/mtna201639f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/fddb341ee138/mtna201639f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/de2dac5281cc/mtna201639f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/8c18264bac35/mtna201639f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/6f1dc5555d13/mtna201639f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/05286e6c2247/mtna201639f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/2a31a08c147a/mtna201639f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/fddb341ee138/mtna201639f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/de2dac5281cc/mtna201639f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db29/5330937/8c18264bac35/mtna201639f6.jpg

相似文献

1
Acid-Sensitive Sheddable PEGylated PLGA Nanoparticles Increase the Delivery of TNF-α siRNA in Chronic Inflammation Sites.酸敏感可脱落聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒增加慢性炎症部位肿瘤坏死因子-α小干扰RNA的递送
Mol Ther Nucleic Acids. 2016 Jul 19;5(7):e340. doi: 10.1038/mtna.2016.39.
2
Acid-Sensitive Sheddable PEGylated, Mannose-Modified Nanoparticles Increase the Delivery of Betamethasone to Chronic Inflammation Sites in a Mouse Model.酸敏感可脱落的聚乙二醇化、甘露糖修饰纳米颗粒提高了地塞米松在小鼠模型中向慢性炎症部位的递送。
Mol Pharm. 2017 Jun 5;14(6):1929-1937. doi: 10.1021/acs.molpharmaceut.7b00024. Epub 2017 May 10.
3
Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate.载脂蛋白纳米颗粒可实现 TNF-αsiRNA 的最小爆发式释放,对甲氨蝶呤治疗无应答的类风湿关节炎具有强大的治疗作用。
J Control Release. 2018 Aug 10;283:280-289. doi: 10.1016/j.jconrel.2018.05.035. Epub 2018 May 31.
4
Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.聚乙二醇化对用于治疗炎症性肠病的载抗体纳米颗粒药物传递系统的影响。
Acta Biomater. 2022 Mar 1;140:561-572. doi: 10.1016/j.actbio.2021.12.015. Epub 2021 Dec 16.
5
Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.用于增强免疫反应的聚合物纳米颗粒:肿瘤抗原与小干扰RNA联合递送至树突状细胞以抑制免疫基因
Acta Biomater. 2014 May;10(5):2169-76. doi: 10.1016/j.actbio.2013.12.050. Epub 2014 Jan 4.
6
In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.载 IFN-α 和聚乙二醇化 IFN-α 的聚(丙交酯-乙交酯)和聚乙二醇化聚(丙交酯-乙交酯)纳米粒的体外 IFN-α 释放。
Nanomedicine (Lond). 2016 Aug;11(16):2029-34. doi: 10.2217/nnm-2016-0058. Epub 2016 Jul 27.
7
Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.采用质量源于设计方法工程化载 siRNA 的脂质体-聚合物杂化纳米粒的固体剂型。
Methods Mol Biol. 2021;2282:137-157. doi: 10.1007/978-1-0716-1298-9_9.
8
Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.载有阿霉素的肿瘤相关巨噬细胞靶向纳米颗粒的生物分布及体内活性
Mol Pharm. 2014 Dec 1;11(12):4425-36. doi: 10.1021/mp500565q. Epub 2014 Oct 27.
9
Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.载 TNF siRNA 的脂质体-聚合物杂化纳米颗粒经关节内给药后可抑制小鼠实验性关节炎模型中的炎症反应。
Eur J Pharm Biopharm. 2019 Sep;142:38-48. doi: 10.1016/j.ejpb.2019.06.009. Epub 2019 Jun 11.
10
MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model.MRI 评估局部给药载抗炎 siRNA 的 PLGA 纳米粒在关节炎模型小鼠中的治疗效果。
J Control Release. 2012 Aug 10;161(3):772-80. doi: 10.1016/j.jconrel.2012.05.004. Epub 2012 May 11.

引用本文的文献

1
IgM has a better relative distribution in inflammation sites and tumor tissues than IgG.与IgG相比,IgM在炎症部位和肿瘤组织中的相对分布更佳。
J Nanobiotechnology. 2025 Mar 28;23(1):253. doi: 10.1186/s12951-025-03213-4.
2
Topical delivery of siRNA to psoriatic skin model using high molecular weight chitosan derivatives: In vitro and in vivo studies.使用高分子量壳聚糖衍生物将小干扰RNA局部递送至银屑病皮肤模型:体外和体内研究
Drug Deliv Transl Res. 2025 Feb 5. doi: 10.1007/s13346-025-01800-4.
3
Exploring the landscape of Lipid Nanoparticles (LNPs): A comprehensive review of LNPs types and biological sources of lipids.

本文引用的文献

1
Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.使用RNAi偶联聚合物纳米药物实现肿瘤选择性沉默
Mol Pharm. 2016 Mar 7;13(3):737-47. doi: 10.1021/acs.molpharmaceut.5b00608. Epub 2016 Feb 2.
2
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.用于验证靶向抑制素1的非小细胞肺癌治疗的长效循环小干扰RNA纳米颗粒
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7779-84. doi: 10.1073/pnas.1505629112. Epub 2015 Jun 8.
3
RNAi Therapeutic Platforms for Lung Diseases.
探索脂质纳米颗粒(LNPs)的全貌:对LNPs类型及脂质生物来源的全面综述
Int J Pharm X. 2024 Nov 18;8:100305. doi: 10.1016/j.ijpx.2024.100305. eCollection 2024 Dec.
4
Nanoparticle-based approaches for treating restenosis after vascular injury.基于纳米颗粒的血管损伤后再狭窄治疗方法。
Front Pharmacol. 2024 Oct 24;15:1427651. doi: 10.3389/fphar.2024.1427651. eCollection 2024.
5
Effect of nanoparticle size on their distribution and retention in chronic inflammation sites.纳米颗粒大小对其在慢性炎症部位分布和滞留的影响。
Discov Nano. 2023 Aug 22;18(1):105. doi: 10.1186/s11671-023-03882-w.
6
Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management.CRISPR/Cas9 变体与肿瘤细胞内刺激响应性靶向方法的基因组编辑技术的最新进展:癌症管理的未来视角。
Int J Mol Sci. 2023 Apr 11;24(8):7052. doi: 10.3390/ijms24087052.
7
Apoptotic body-inspired nanoparticles target macrophages at sites of inflammation to support an anti-inflammatory phenotype shift.凋亡小体启发的纳米颗粒靶向炎症部位的巨噬细胞,以支持抗炎表型转变。
Int J Pharm. 2022 Apr 25;618:121634. doi: 10.1016/j.ijpharm.2022.121634. Epub 2022 Mar 3.
8
Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases.炎症响应型递药系统治疗慢性炎症性疾病。
Drug Deliv Transl Res. 2021 Aug;11(4):1475-1497. doi: 10.1007/s13346-021-00977-8. Epub 2021 Apr 15.
9
Carbon Nanotubes-Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis.碳纳米管——类风湿关节炎靶向给药的高效载体
Pharmaceutics. 2021 Mar 27;13(4):453. doi: 10.3390/pharmaceutics13040453.
10
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.组织特异性递送 CRISPR 治疗药物:非病毒载体的策略和机制。
Int J Mol Sci. 2020 Oct 5;21(19):7353. doi: 10.3390/ijms21197353.
用于肺部疾病的 RNAi 治疗平台。
Pharmaceuticals (Basel). 2013 Feb 6;6(2):223-50. doi: 10.3390/ph6020223.
4
TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.采用聚合 siRNA/巯基化壳聚糖纳米粒沉默 TNF-α 基因治疗类风湿关节炎。
Mol Ther. 2014 Feb;22(2):397-408. doi: 10.1038/mt.2013.245. Epub 2013 Oct 22.
5
In vivo imaging method to distinguish acute and chronic inflammation.区分急性和慢性炎症的体内成像方法。
J Vis Exp. 2013 Aug 16(78):50690. doi: 10.3791/50690.
6
Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.聚乙二醇可脱落、甘露糖修饰的纳米颗粒实现对肿瘤相关巨噬细胞的靶向作用。
Mol Pharm. 2013 Sep 3;10(9):3525-30. doi: 10.1021/mp400216r. Epub 2013 Aug 6.
7
EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference.EGF-EGFP 缀合的 PLGA 纳米粒用于靶向递送至损伤的脑微血管内皮细胞中的 siRNA 以实现有效的 RNA 干扰。
PLoS One. 2013 Apr 10;8(4):e60860. doi: 10.1371/journal.pone.0060860. Print 2013.
8
The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression.载 4-(N)-硬脂酰基吉西他滨的胶束的酸敏感性对 RRM1 过表达引起的耐药性的影响。
Biomaterials. 2013 Mar;34(9):2327-39. doi: 10.1016/j.biomaterials.2012.11.053. Epub 2012 Dec 20.
9
PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints.载有 siRNA 抗 TNFalpha 的 PLGA 微球:高效的 RNAi 介导的关节炎关节治疗。
Eur J Pharm Biopharm. 2012 Nov;82(3):457-64. doi: 10.1016/j.ejpb.2012.07.021. Epub 2012 Aug 16.
10
The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.通过双模式成像研究纳米粒子聚乙二醇表面密度对配体导向肿瘤靶向的体内影响。
ACS Nano. 2012 Jun 26;6(6):5648-58. doi: 10.1021/nn301630n. Epub 2012 Jun 6.